, Algorithmes systématiques de prise en charge des patients sous antithrombotiques issus des recommandations de la SFCO, 2015.

A. Bibliographie, Les anticoagulants en France en 2014 : état des lieux, synthèse et surveillance, ANNEXE, vol.1, 2014.

, Antiagrégants plaquettaires : prise en compte des risques thrombotique et hémorragique pour les gestes percutanés chez le coronarien, HAS. Les anticoagulants oraux, 1997.

M. Huisse, D. Faille, and N. Ajzenberg, Exploration de l'hémostase primaire, EMC-Angéiologie, vol.12, issue.1, pp.1-7, 2017.

A. Bezeaud and M. Guillin, Physiologie de la coagulation, Encycl Med Chir, vol.7, 2001.

R. Marlu, Physiologie de l'hémostase. Oxymag, vol.29, issue.146, pp.10-15, 2016.

Y. Nizamaldin, A. Najm, S. , E. Hage, M. Samson et al., Hémostase locale en chirurgie orale. Partie 1 : physiologie de l'hémostase, Médecine Buccale Chir Buccale. avr, vol.18, issue.2, pp.119-146, 2012.

J. J. Eledjam, J. F. Schved, and J. Bonnafoux, Physiologie de l'hémostase, Ann Fr Anesth Réanimation. 1 janv, vol.4, issue.3, pp.35-42, 1985.

T. De-revel, Physiologie de l'hémostase The Normal Haemostatic Process, p.11

S. Duboeuf, F. Pillon, S. L'hémostase-;-boisramé-gastrin, J. F. Abgrall, M. P. Guillodo et al., Les examens biologiques en chirurgie orale. Manuel de chirurgie orale technique de réalisation pratique, Actual Pharm. déc, vol.49, issue.501, pp.14-19, 2010.

W. Ageno, A. S. Gallus, A. Wittkowsky, M. Crowther, E. M. Hylek et al., HAS. Biologie des anomalies de l'hémostase, vol.141, pp.44-48, 2012.

G. H. Guyatt, E. A. Akl, M. Crowther, D. D. Gutterman, and H. J. Schuünemann, Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, CHEST. 1 févr, vol.141, issue.2, pp.7-47, 2012.

H. Ansm, K. K. Motlagh, I. Loeb, W. Legrand, P. Daelemans et al., Prévention des saignements postopératoires chez des patients sous anticoagulants oraux. Effets de l'acide tranexamique, Rev Stomatol Chir Maxillofac, vol.120, pp.77-86, 2003.

P. Ameli-;-casais, A. S. Luceros, S. Meschengieser, C. Fondevila, M. T. Santarelli et al., HAS. Prise en charge des surdosages, des situations à risque hémorragique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier, Am J Hematol. 1 avr, vol.63, issue.4, pp.192-198, 2000.

C. Lansonneur, P. Guillou, A. Hacquard, M. Devisse, J. Lelievre et al., Les nouveaux anticoagulants oraux (dabigatran et rivaroxaban) dans la fibrillation auriculaire : ce qu'il faut savoir -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé, Médecine Buccale Chir Buccale, vol.11, issue.1, pp.11-20, 2013.

M. Levi, Management of bleeding in patients treated with direct oral anticoagulants, Crit Care. 20 août, vol.20, p.249, 2016.

M. M. Levi, E. Eerenberg, E. Löwenberg, and P. W. Kamphuisen, Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management, Neth J Med. févr, vol.68, issue.2, pp.68-76, 2010.

S. Schulman, Advantages and limitations of the new anticoagulants, J Intern Med. janv, vol.275, issue.1, pp.1-11, 2014.

P. Mismetti and S. Laporte, Rivaroxaban : données pharmaco-cliniques, Ann Fr Anesth Réanimation. déc, vol.27, pp.16-21, 2008.

P. C. Wong, E. J. Crain, B. Xin, R. R. Wexler, P. Lam et al., Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies, J Thromb Haemost. 1 mai, vol.6, issue.5, pp.820-829, 2008.

C. Czembirek, W. P. Poeschl, C. Eder-czembirek, M. B. Fischer, C. Perisanidis et al., Causes and timing of delayed bleeding after oral surgery, Clin Oral Investig. 1 juill, vol.18, issue.6, pp.1655-61, 2014.

P. Gangloff, Prise en charge des patients traités par agents antiplaquettaires et antivitamines. In: Manuel de chirurgie orale : Technique de réalisation pratique, maîtrise et exercice raisonné au quotidien, CdP, p.536, 2012.

D. Blinder, Y. Manor, U. Martinowitz, and S. Taicher, Dental extractions in patients maintained on oral anticoagulant therapy: Comparison of INR value with occurrence of postoperative bleeding

, Int J Oral Maxillofac Surg. 1 déc, vol.30, issue.6, pp.518-539, 2001.

F. Daïmellah, M. S. Issad, S. Lehachi, Z. Bennoui, S. Khelil et al., Facteurs de risque hémorragique chez les patients sous antivitamine K en chirurgie buccale. Médecine Buccale Chir Buccale, vol.16, pp.209-224, 2010.

J. Garnier, F. Truchot, J. Quero, X. Meziere, F. Clipet et al., Antiagrégant plaquettaire et chirurgie buccale: à propos de 218 extractions dentaires, Rev Stomatol Chir Maxillofac, vol.108, issue.5, pp.407-417, 2007.

R. Gaspar, B. Brenner, L. Ardekian, M. Peled, and D. Laufer, Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication, Quintessence Int. juin, vol.28, issue.6, pp.375-384, 1997.

P. S. Myles, J. A. Smith, A. Forbes, B. Silbert, M. Jayarajah et al., Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery, N Engl J Med. 12 janv, vol.376, issue.2, pp.136-184, 2017.

G. Borea, L. Montebugnoli, P. Capuzzi, and C. Magelli, Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. Oral Surg Oral Med Oral Pathol, janv, vol.75, issue.1, pp.29-31, 1993.

G. Ramström, S. Sindet-pedersen, G. Hall, M. Blombäck, and U. Älander, Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants, J Oral Maxillofac Surg, vol.51, issue.11, pp.1211-1217, 1993.

M. Hamon, M. Dupres, and S. Wisniewski, Produits pharmaceutiques à visée hémostatique : physiopathologie, propriétés et utilisation, Pharmacien Hospitalier et Clinicien. Juin, vol.51, pp.3-18, 2016.

Y. Nizamaldin and J. Samson, Hémostase locale en Chirurgie orale. Partie 2 : efficacité de la colle de fibrine, Conseils post-opératoires en chirurgie orale, vol.18, 2012.

M. A. Crowther and T. E. Warkentin, Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents, Blood. 15 mai, vol.111, issue.10, pp.4871-4880, 2008.

M. Makris, J. Veen, C. R. Tait, A. D. Mumford, and M. Laffan, Guideline on the management of bleeding in patients on antithrombotic agents, Br J Haematol. 1 janv, vol.160, issue.1, pp.35-46, 2013.

M. Lordkipanidzé, J. G. Diodati, and C. Pharand, Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: A look at the clinical and pharmacological evidence, Pharmacol Ther. 1 août, vol.123, issue.2, pp.178-86, 2009.

C. L. Grines, R. O. Bonow, D. E. Casey, T. J. Gardner, P. B. Lockhart et al., Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents: A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of Physicians, Circulation. 13 févr, vol.115, issue.6, pp.813-821, 2007.

T. Lillis, A. Ziakas, K. Koskinas, A. Tsirlis, and G. Giannoglou, Safety of Dental Extractions During Uninterrupted Single or Dual Antiplatelet Treatment, Am J Cardiol, vol.108, issue.7, pp.964-971, 2011.

L. Ardekian, R. Gaspar, M. Peled, B. Brener, and D. Laufer, Does low-dose aspirin therapy complicate oral surgical procedures?, J Am Dent Assoc. mars, vol.131, issue.3, pp.331-336, 2000.

Y. Morimoto, H. Niwa, and K. Minematsu, Hemostatic management of tooth extractions in patients on oral antithrombotic therapy, J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. janv, vol.66, issue.1, pp.51-58, 2008.

M. T. Brennan, M. A. Valerin, J. L. Noll, J. J. Napeñas, M. L. Kent et al., Aspirin Use and Post-operative Bleeding from Dental Extractions, J Dent Res. août, vol.87, issue.8, pp.740-744, 2008.

B. Krishnan, N. A. Shenoy, and M. Alexander, Exodontia and Antiplatelet Therapy, J Oral Maxillofac Surg, vol.66, issue.10, pp.2063-2069, 2008.

G. Verma, J. J. Napeñas, C. Hong, M. T. Brennan, S. L. Furney et al., The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy, Dental Extraction Can Be Performed Safely in Patients on Aspirin Therapy: A Timely Reminder, vol.56, pp.1044-50, 1939.

F. Daïmellah, M. Issad, H. Boukaïs, W. Zerrouki, M. Berkane et al., Avulsions dentaires chez les patients cardiaques traités par anticoagulants : résultats d'un essai thérapeutique acénocoumarol versus héparine calcique, 59. Nematullah A. Dental Surgery for Patients on Anticoagulant Therapy with Warfarin: A Systematic Review and Meta-analysis, vol.15, issue.2, p.10, 2009.

M. J. Wahl, Dental Surgery in Anticoagulated Patients, Arch Intern Med. 10 août, vol.158, issue.15, pp.1610-1616, 1998.

D. J. Perry, T. Noakes, and P. S. Helliwell, Guidelines for the management of patients on oral anticoagulants requiring dental surgery, Br Dent J. oct, vol.203, issue.7, pp.389-93, 2007.

S. Sivolella, D. Biagi, M. Brunello, G. Berengo, M. Pengo et al., Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants, Odontology. sept, vol.103, issue.3, pp.258-63, 2015.

J. H. Levy and M. Levi, New oral anticoagulant-induced bleeding: clinical presentation and management, Clin Lab Med. sept, vol.34, issue.3, pp.575-86, 2014.

, Prise en charge des patients sous agents antiplaquettaires en odontostomatologie. Recommandations

A. Cloitre, X. Duval, and P. Lesclous, Antibioprophylaxie de l'endocardite infectieuse, respect des recommandations de bonne pratique

M. Buccale and C. Buccale, Epidémiologie des professionnels de santé, juill, vol.20, issue.3, pp.141-53, 2014.

Y. L. Chee, J. C. Crawford, H. G. Watson, and M. Greaves, Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures, Br J Haematol. 1 mars, vol.140, issue.5, pp.496-504, 2008.

L. Abraham-inpijn, G. Russell, D. A. Abraham, N. Bäckman, E. Baum et al., A patient-administered Medical Risk Related History questionnaire (EMRRH) for use in 10

, European countries (multicenter trial). Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology, vol.105, pp.597-605, 2008.

M. Glick, The health questionnaire, J Am Dent Assoc. juill, vol.138, issue.7, pp.932-936, 2007.

D. E. Van-diermen, J. Bruers, J. Hoogstraten, M. Bovenlander, A. Van-den-bosch et al., Treating dental patients who use oral antithrombotic medication, J Am Dent Assoc. déc, vol.142, issue.12, pp.1376-82, 2011.

R. Chinnaswami and . Dentists'-knowledge, Cannon PD, Dharmar VT. Minor oral surgical procedures in patients on oral anticoagulants -a controlled study, Aust Dent J. 1 juin, vol.11, issue.1, pp.115-123, 2003.

I. L. Evans, M. S. Sayers, A. J. Gibbons, G. Price, H. Snooks et al., Can warfarin be continued during dental extraction? Results of a randomized controlled trial, Br J Oral Maxillofac Surg. juin, vol.40, issue.3, pp.248-52, 2002.

C. Davis, C. Robertson, S. Shivakumar, and M. Lee, Implications of Dabigatran, a Direct Thrombin Inhibitor, for Oral Surgery Practice, J Can Dent Assoc, vol.7, 2013.

L. Devoize, A. Durand, S. Tubert-jeannin, C. Deschaumes, C. Huard et al.,

, Etude de l'activité chirurgicale des praticiens libéraux en Auvergne, Médecine Buccale Chir Buccale, vol.12, issue.2, pp.63-72, 2006.

M. Massot, F. Clipet, N. Alno, J. Garnier, B. Köhler et al., Étude épidémiologique sur les extractions dentaireschez les patients sous AVK en Ille-et-Vilaine, Médecine Buccale Chir Buccale, vol.15, pp.29-37, 2009.

D. A. Garcia, S. Regan, L. E. Henault, A. Upadhyay, J. Baker et al., Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy, Arch Intern Med. 14 janv, vol.168, issue.1, pp.63-72, 2008.

F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave et al., Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment, Circulation. 14 août, vol.116, issue.7, pp.745-54, 2007.

P. Chassot, A. Delabays, and D. R. Spahn, Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction, Br J Anaesth. 1 sept, vol.99, issue.3, pp.316-344, 2007.

S. E. Akopov, S. Suzuki, A. Fredieu, C. S. Kidwell, J. L. Saver et al., Withdrawal of Warfarin prior to a Surgical Procedure: Time to Follow the Guidelines?, Cerebrovasc Dis, vol.19, issue.5, pp.337-379, 2005.

G. Biondi-zoccai, M. Lotrionte, P. Agostoni, A. Abbate, M. Fusaro et al., A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease, Eur Heart J, vol.27, issue.22, pp.2667-74, 2006.

C. Minassian, D. 'aiuto, F. Hingorani, A. D. Smeeth, and L. , Invasive Dental Treatment and Risk for Vascular Events: A Self-Controlled Case Series, Ann Intern Med, vol.153, issue.8, p.499, 2010.

N. Sambu, T. Warner, N. Curzen, D. E. Van-diermen, I. Van-der-waal et al., Survey response of oral and maxillofacial surgeons on invasive procedures in patients using antithrombotic medication, Int J Oral Maxillofac Surg. avr, vol.105, issue.02, pp.502-509, 2011.